Transport Topics – New York City and Los Angeles, worried that a Senate self-driving car bill would make them hand over control of their streets to the federal government, have found a powerful ally.
MIT Technology Review – A trial planning to use the gene-editing tool CRISPR on sickle-cell patients has been put on hold because of unspecified questions from US regulators.
National Institutes of Health – Experts put forward recommendations that provide a roadmap for an integrated, multidisciplinary research agenda necessary to inform priorities for Alzheimer’s disease.
US Food and Drug Administration – The FDA permitted marketing of Imagen OsteoDetect, a type of computer-aided detection and diagnosis software designed to detect wrist fractures in adult patients.
Azcentral – Uber is shutting down its self-driving car tests in Arizona, where one of the cars was involved in a fatal crash with a pedestrian in March, the company said Wednesday.
STAT – The Food and Drug Administration will soon be alerting companies that certain gene therapies in development can qualify for less arduous review at the agency.
The Detroit News – The nomination of President Trump’s pick to lead the National Highway Traffic Safety Administration is facing signs of trouble after a Senate committee postponed a Tuesday vote on whether her nomination should move forward.
The Daily Herald – The suspect was arrested for investigation of first-degree murder. He was determined to be the only potential suspect through a new forensic technology known as genetic genealogy.
The New York Times – The approval ushers in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.
The Washington Post – A federal appeals court found that restrictions against harming wildlife are inadequate for the controversial 600-mile natural gas project.